Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
This study has been completed.
Study NCT00438776   Information provided by Lindner Center of HOPE

First Received on February 20, 2007.   Last Updated on December 12, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pathological Gambling
Additional conditions recognized in this trial
Gambling
More general conditions related to this trial
Impulse Control Disorders
Mental Disorders
Interventions listed in this trial
olanzapine
sugar pill
Additional drug interventions recognized in this trial
Contraceptives, Oral
More general drug interventions related to this trial
Antiemetics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Contraceptive Agents
Contraceptive Agents, Female
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Reproductive Control Agents
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Lindner Center of HOPE
Eli Lilly and Company
University of Cincinnati


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services